Trial reportCirculation. Cardiovascular genetics2012
Randomized trial of personal genomics for preventive cardiology: design and challenges.
Trial report in Circulation. Cardiovascular genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Pilot Randomized Trial of Personal Genomics for Preventive Cardiology
MyHeart Counts Cardiovascular Health Study
Who cites it
17 citing papers in PubMed.
- The association between psychosocial factors and change in lifestyle behaviour following lifestyle advice and information about cardiovascular disease risk.BMC public health · 2018Trial
- Trial
- Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study.BMC medical genomics · 2015Trial
- Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes.Contemporary clinical trials · 2014Trial
- Efficacy of polygenic risk scores and digital technologies for INNOvative personalized cardiovascular disease PREVention in high-risk adults: protocol of a randomized controlled trial.Frontiers in public health · 2024Article
- How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?Current atherosclerosis reports · 2021Review
- Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications.Circulation research · 2020Review
- Cardiovascular disease: The rise of the genetic risk score.PLoS medicine · 2018Article
- Impact of a Genetic Risk Score for Coronary Artery Disease on Reducing Cardiovascular Risk: A Pilot Randomized Controlled Study.Frontiers in cardiovascular medicine · 2017Article
- The response to receiving phenotypic and genetic coronary heart disease risk scores and lifestyle advice - a qualitative study.BMC public health · 2016Article
- Implementing genomics and pharmacogenomics in the clinic: The National Human Genome Research Institute's genomic medicine portfolio.Atherosclerosis · 2016Review
- Article
- Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example.Frontiers in genetics · 2014Article
- Genetics of coronary artery disease.Circulation · 2013Review
- Genomic medicine for improved prediction and primordial prevention of cardiovascular disease.Arteriosclerosis, thrombosis, and vascular biology · 2013Article
- Bringing genome-wide association findings into clinical use.Nature reviews. Genetics · 2013Review
- Exploring predisposition and treatment response--the promise of genomics.Progress in cardiovascular diseasesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.